FREEDOM Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorNeuspera Medical, Inc.

About this trial

Single-arm study where subjects' responses to a questionnaire for the traditional Sacral Neuromodulation (SNM) devices will be compared to the responses regarding the Neuspera SNM System.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Currently have a traditional SNM device and has decided to have the device replaced with the Neuspera SNM System OR previously had an existing traditional SNM implant that was completely removed within the last year

Is 22 years of age or older

Had documented at least 50% improvement in UUI episodes on a bladder diary with either a stimulation trial or with their traditional system

Is a good surgical candidate and qualified to receive the Neuspera SNM System per the device labeling

Disqualifiers

Has a contraindication for the Neuspera SNM System per the device labeling.

Has plans to enroll or is currently enrolled in another investigational device or drug trial during his/her participation in this study

Trial population

Study population with 22 years of age or older and who have or have previously had a traditional SNM system.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Neuspera Implantable Sacral Neuromodulation System

    Device

    Stimulation of the Sacral Nerve

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Neuspera Replacement Cohort1 intervention

Trial outcomes

Primary outcomes

1

Primary Study measure

The changes to subject questionnaire responses for the Neuspera SNM system compared to responses regarding traditional SNM systems

Time frame
1 month

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: